272 related articles for article (PubMed ID: 36062286)
1. Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research.
Li M; Zhou X; Wang W; Ji B; Shao Y; Du Q; Yao J; Yang Y
J Clin Transl Hepatol; 2022 Aug; 10(4):700-710. PubMed ID: 36062286
[TBL] [Abstract][Full Text] [Related]
2. Animal models of cholangiocarcinoma.
Ko KS; Peng J; Yang H
Curr Opin Gastroenterol; 2013 May; 29(3):312-8. PubMed ID: 23434850
[TBL] [Abstract][Full Text] [Related]
3. Current Advances in Basic and Translational Research of Cholangiocarcinoma.
Sato K; Baiocchi L; Kennedy L; Zhang W; Ekser B; Glaser S; Francis H; Alpini G
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282753
[TBL] [Abstract][Full Text] [Related]
4. Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research.
Erice O; Vallejo A; Ponz-Sarvise M; Saborowski M; Vogel A; Calvisi DF; Saborowski A; Vicent S
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31769429
[TBL] [Abstract][Full Text] [Related]
5. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma.
Vicent S; Lieshout R; Saborowski A; Verstegen MMA; Raggi C; Recalcati S; Invernizzi P; van der Laan LJW; Alvaro D; Calvisi DF; Cardinale V
Liver Int; 2019 May; 39 Suppl 1():79-97. PubMed ID: 30851232
[TBL] [Abstract][Full Text] [Related]
6. Developing models of cholangiocarcinoma to close the translational gap in cancer research.
Waddell SH; Boulter L
Expert Opin Investig Drugs; 2021 Apr; 30(4):439-450. PubMed ID: 33513027
[No Abstract] [Full Text] [Related]
7. Cholangiocarcinoma: increasing burden of classifications.
Cardinale V; Bragazzi MC; Carpino G; Torrice A; Fraveto A; Gentile R; Pasqualino V; Melandro F; Aliberti C; Bastianelli C; Brunelli R; Berloco PB; Gaudio E; Alvaro D
Hepatobiliary Surg Nutr; 2013 Oct; 2(5):272-80. PubMed ID: 24570958
[TBL] [Abstract][Full Text] [Related]
8. Animal models of cholangiocarcinoma: What they teach us about the human disease.
Cadamuro M; Brivio S; Stecca T; Kaffe E; Mariotti V; Milani C; Fiorotto R; Spirli C; Strazzabosco M; Fabris L
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):403-415. PubMed ID: 29753731
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma in patients with primary sclerosing cholangitis.
Fung BM; Tabibian JH
Curr Opin Gastroenterol; 2020 Mar; 36(2):77-84. PubMed ID: 31850928
[TBL] [Abstract][Full Text] [Related]
10. The importance of preclinical models in cholangiocarcinoma.
McGreevy O; Bosakhar M; Gilbert T; Quinn M; Fenwick S; Malik H; Goldring C; Randle L
Eur J Surg Oncol; 2024 Mar; ():108304. PubMed ID: 38653585
[TBL] [Abstract][Full Text] [Related]
11. Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.
Cardinale V; Semeraro R; Torrice A; Gatto M; Napoli C; Bragazzi MC; Gentile R; Alvaro D
World J Gastrointest Oncol; 2010 Nov; 2(11):407-16. PubMed ID: 21160904
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered animal models of biliary tract cancers.
Pirenne S; Lemaigre FP
Curr Opin Gastroenterol; 2020 Mar; 36(2):90-98. PubMed ID: 31850929
[TBL] [Abstract][Full Text] [Related]
13. Future directions in the treatment of cholangiocarcinoma.
Zhu AX
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
[TBL] [Abstract][Full Text] [Related]
15. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma.
Yeh CN; Maitra A; Lee KF; Jan YY; Chen MF
Carcinogenesis; 2004 Apr; 25(4):631-6. PubMed ID: 14656942
[TBL] [Abstract][Full Text] [Related]
16. A novel mouse model of orthotopic extrahepatic cholangiocarcinoma confirmed with molecular imaging.
Song X; Shao Z; Han M; Liang H
Transl Cancer Res; 2019 Apr; 8(2):583-591. PubMed ID: 35116791
[TBL] [Abstract][Full Text] [Related]
17. New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.
Bragazzi MC; Ridola L; Safarikia S; Matteo SD; Costantini D; Nevi L; Cardinale V
Ann Gastroenterol; 2018; 31(1):42-55. PubMed ID: 29333066
[TBL] [Abstract][Full Text] [Related]
18. Cell of origin in biliary tract cancers and clinical implications.
Moeini A; Haber PK; Sia D
JHEP Rep; 2021 Apr; 3(2):100226. PubMed ID: 33665585
[TBL] [Abstract][Full Text] [Related]
19. Evolution of the Experimental Models of Cholangiocarcinoma.
Massa A; Varamo C; Vita F; Tavolari S; Peraldo-Neia C; Brandi G; Rizzo A; Cavalloni G; Aglietta M
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824407
[TBL] [Abstract][Full Text] [Related]
20. Moving forward in the treatment of cholangiocarcinoma.
Manzia TM; Parente A; Lenci I; Sensi B; Milana M; Gazia C; Signorello A; Angelico R; Grassi G; Tisone G; Baiocchi L
World J Gastrointest Oncol; 2021 Dec; 13(12):1939-1955. PubMed ID: 35070034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
